Photo of Amy L. Billett,  MD

Amy L. Billett, MD

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute
Phone: (617) 632-5640
Fax: (617) 632-4811


amy_billett@dfci.harvard.edu

Amy L. Billett, MD

Dana-Farber Cancer Institute

EDUCATIONAL TITLES

  • Associate Professor, Pediatrics, Harvard Medical School
  • Associate in Medicine, Hematology-Oncology, Boston Children's Hospital
  • Clinical Associate, Pediatrics, Dana-Farber Cancer Institute

DF/HCC PROGRAM AFFILIATION

Research Abstract

Our clinical research focuses on improving the long-term outcome for children with Hodgkin's disease. We also are involved in defining and measuring medication error, and developing systems to prevent it. Our other research interests include relapsed acute lymphoblastic leukemia (ALL) and chemotherapy-induced nausea and vomiting.

Publications

Powered by Harvard Catalyst
  • Bundy DG, Gaur AH, Billett AL, He B, Colantuoni EA, Miller MR, . Preventing CLABSIs among pediatric hematology/oncology inpatients: national collaborative results. Pediatrics 2014; 134:e1678-85. PubMed
  • Billett AL. Avoiding risky business: supporting optimal home medication administration for children with cancer. J Oncol Pract 2014; 10:377-9. PubMed
  • Croteau SE, Henderson ER, Billett AL, Gebhardt MC, Voss SD. Resolving bony abnormality evolves to diffuse large B-cell lymphoma. Pediatr Blood Cancer 2013; 60:E113-5. PubMed
  • Friedmann AM, Wolfson JA, Hudson MM, Weinstein HJ, Link MP, Billett A, Larsen EC, Yock T, Donaldson SS, Marcus K, Krasin MJ, Howard SC, Metzger ML. Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy. Pediatr Blood Cancer 2013; 60:1458-63. PubMed
  • Walsh KE, Roblin DW, Weingart SN, Houlahan KE, Degar B, Billett A, Keuker C, Biggins C, Li J, Wasilewski K, Mazor KM. Medication errors in the home: a multisite study of children with cancer. Pediatrics 2013; 131:e1405-14. PubMed
  • Gaur AH, Bundy DG, Gao C, Werner EJ, Billett AL, Hord JD, Siegel JD, Dickens D, Winkle C, Miller MR, . Surveillance of hospital-acquired central line-associated bloodstream infections in pediatric hematology-oncology patients: lessons learned, challenges ahead. Infect Control Hosp Epidemiol 2013; 34:316-20. PubMed
  • Kelly MS, Conway M, Wirth KE, Potter-Bynoe G, Billett AL, Sandora TJ. Microbiology and risk factors for central line-associated bloodstream infections among pediatric oncology outpatients: a single institution experience of 41 cases. J. Pediatr. Hematol. Oncol. 2013; 35:e71-6. PubMed
  • Metzger ML, Weinstein HJ, Hudson MM, Billett AL, Larsen EC, Friedmann A, Howard SC, Donaldson SS, Krasin MJ, Kun LE, Marcus KJ, Yock TI, Tarbell N, Billups CA, Wu J, Link MP. Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. JAMA 2012; 307:2609-16. PubMed
  • Feusner JH,Ritchey AK,Cohn SL,Billett AL. Management of tumor lysis syndrome: need for evidence-based guidelines. J Clin Oncol 2008; 26:5657-8; author reply 5658-9. PubMed
  • Donaldson SS, Link MP, Weinstein HJ, Rai SN, Brain S, Billett AL, Hurwitz CA, Krasin M, Kun LE, Marcus KC, Tarbell NJ, Young JA, Hudson MM. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol 2007; 25:332-7. PubMed
  • Carpentieri SC, Waber DP, Pomeroy SL, Scott RM, Goumnerova LC, Kieran MW, Billett AL, Tarbell NJ. Neuropsychological functioning after surgery in children treated for brain tumor. Neurosurgery 2003; 52:1348-56; discussion 1356-. PubMed